Short description
ARIAD is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients.
Description
ARIAD is a Cambridge, Massachusetts-based biotechnology company focused on cancer. We are a cohesive team of talented people from diverse backgrounds with a shared vision: We seek to transform the lives of patients with breakthrough cancer medicines. This is our purpose. This is our passion. This is our promise.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 1991
Closed on
February 16, 2017
Exited on
September 30, 1994
Went public on
September 30, 1994
Delisted on
February 16, 2017
Stock symbol
ARIA
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$1230 - 4560
Sign in for full access
Investors
Absolutely Noaccess, Noway Youcantaccess
Sign in for full access
Founders
Harvey Berger, Larry Bock
Funding rounds count
1
Portfolio organisations count
Cannot Access, Uh Ohhhh
Sign in for full access
Exits count
Absolutely Noaccess, No Way
Sign in for full access
IPO exits count
1